Return to content in this issue


Successful Treatment of Corticosteroid-Refractory Hypereosinophilia With Reslizumab

Coffey K*, Fajt ML*, Acho M, Gladwin M, Petrov AA

Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA
*Both authors contributed equally to the manuscript.

J Investig Allergol Clin Immunol 2019; Vol 29(3) : 241-242
doi: 10.18176/jiaci.0366

Key words: Hypereosinophilia, Treatment, Reslizumab